Raymond James & Associates’s OmniAb OABI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,333
Closed -$60.1K 3930
2023
Q1
$60.1K Sell
16,333
-49
-0.3% -$185 ﹤0.01% 3716
2022
Q4
$59K Buy
+16,382
New +$86K ﹤0.01% 3703

Other funds holding OABI

Raymond James & Associates's OABI Position: Q2 2023 in Review

Raymond James & Associates sold out of OmniAb (OABI) in Q2 2023, closing a stake of 16,333 shares — an estimated $60.1K sold.

Raymond James & Associates first reported a position in OABI in Q4 2022 and held it in 2 quarters. The position peaked at $60.1K in Q1 2023. 144 funds tracked by Wall St. Rank hold OABI as of Q2 2023.

  • Raymond James & Associates reported no remaining OmniAb position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 16,333 OmniAb shares in Q2 2023, an estimated $60.1K.
  • Raymond James & Associates first reported a position in OmniAb in Q4 2022 and held it in 2 quarters.
  • Raymond James & Associates's OmniAb position peaked at $60.1K in Q1 2023.
  • 144 funds tracked by Wall St. Rank held OmniAb as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.